Placebo effect in pharmacological management of fibromyalgia: a meta-analysis.
fibromyalgia
management
placebodrug
Journal
British medical bulletin
ISSN: 1471-8391
Titre abrégé: Br Med Bull
Pays: England
ID NLM: 0376542
Informations de publication
Date de publication:
10 09 2021
10 09 2021
Historique:
received:
10
03
2021
revised:
18
06
2021
accepted:
25
06
2021
pubmed:
24
7
2021
medline:
5
11
2021
entrez:
23
7
2021
Statut:
ppublish
Résumé
The management of fibromyalgia involves a combination of pharmacological and non-pharmacological treatments. Recently published literature in PubMed, Google Scholar and Embase databases. Several pharmacological and non-pharmacological strategies have been proposed for the management of fibromyalgia. However, the management of fibromyalgia remains controversial. The administration of placebo has proved to be more effective than no treatment in many clinical settings and evidence supports the 'therapeutic' effects of placebo on a wide range of symptoms. The placebo effect is believed to impact the clinical outcomes, but its actual magnitude is controversial. A meta-analysis comparing pharmacological management versus placebo administration for fibromyalgia was conducted. Drug treatment resulted to be more effective than placebo administration for the management of fibromyalgia. Nevertheless, placebo showed a beneficial effect in patients with fibromyalgia. Treatment-related adverse events occurred more frequently in the drug treatment. I, Bayesian network meta-analysis of double-blind randomized clinical trials.
Identifiants
pubmed: 34296741
pii: 6326041
doi: 10.1093/bmb/ldab015
doi:
Types de publication
Journal Article
Meta-Analysis
Langues
eng
Sous-ensembles de citation
IM
Pagination
73-85Informations de copyright
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.